Sahasrabudhe DM - Search Results

1

Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.

Woodlock TJ, Sahasrabudhe DM, Marquis DM, Greene D, Pandya KJ, McCune CS. Woodlock TJ, et al. Among authors: sahasrabudhe dm. J Immunother. 1999 May;22(3):251-9. doi: 10.1097/00002371-199905000-00008. J Immunother. 1999. PMID: 10335485 Clinical Trial.

2

Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells.

McCune CS, O'Donnell RW, Marquis DM, Sahasrabudhe DM. McCune CS, et al. Among authors: sahasrabudhe dm. Cancer Immunol Immunother. 1990;32(1):62-6. doi: 10.1007/BF01741726. Cancer Immunol Immunother. 1990. PMID: 2289200 Free PMC article. Clinical Trial.

3

Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma.

Sahasrabudhe DM, deKernion JB, Pontes JE, Ryan DM, O'Donnell RW, Marquis DM, Mudholkar GS, McCune CS. Sahasrabudhe DM, et al. J Biol Response Mod. 1986 Dec;5(6):581-94. J Biol Response Mod. 1986. PMID: 3491881

4

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.

Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Ladrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, Slos P, Squiban P, Ross M, Kendra K. Khorana AA, et al. Among authors: sahasrabudhe dm. Cancer Gene Ther. 2003 Apr;10(4):251-9. doi: 10.1038/sj.cgt.7700568. Cancer Gene Ther. 2003. PMID: 12679797 Clinical Trial.

5

Human hybrid tumor cells: observations on their production and clinical effects.

McCune CS, Henshaw EC, Marquis DM, Sahasrabudhe D, Leary J, O'Donnell RW. McCune CS, et al. Among authors: sahasrabudhe d. J Biol Response Mod. 1987 Apr;6(2):130-40. J Biol Response Mod. 1987. PMID: 3585410

6

Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.

Pandya KJ, Thummala AR, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA. Pandya KJ, et al. Among authors: sahasrabudhe dm. Breast Cancer Res Treat. 2004 Jan;83(1):87-9. doi: 10.1023/B:BREA.0000010676.54597.22. Breast Cancer Res Treat. 2004. PMID: 14997058 Clinical Trial.

7

Five tumors over six years in eighth decade of life.

Corbin K, Fisher S, Sahasrabudhe D, Pandya K, Brasacchio R, Constine LS. Corbin K, et al. Cancer Invest. 2008 Jul;26(6):634-7. doi: 10.1080/07357900701781838. Cancer Invest. 2008. PMID: 18584355

8

Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

Sahasrabudhe DM, McCune CS, O'Donnell RW, Henshaw EC. Sahasrabudhe DM, et al. J Immunol. 1987 May 1;138(9):2760-3. J Immunol. 1987. PMID: 2952721

9

Effect of murine interferon alpha/beta on tumour-induced suppressor function.

Sahasrabudhe DM, Dusel JC. Sahasrabudhe DM, et al. Cancer Immunol Immunother. 1994 Dec;39(6):360-6. doi: 10.1007/BF01534422. Cancer Immunol Immunother. 1994. PMID: 8001023 Free PMC article.

10

Suppression of delayed type hypersensitivity by desferoxamine.

Sahasrabudhe DM, Dusel J, Jedlika S. Sahasrabudhe DM, et al. J Immunother (1991). 1991 Apr;10(2):112-9. doi: 10.1097/00002371-199104000-00005. J Immunother (1991). 1991. PMID: 2043591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters